2m 2m 2m 2m 2m 2m 2m
Ensign Group (ENSG)
NASDAQ
$159.04+$2.25 (+1.44%)
Price as of Jun 23, 2026 6:58 PM EDT- $9.2BMarket Cap
- 3.18%1-Year Change
- Medical Care FacilitiesIndustry
Ensign Group (ENSG)
$159.04+$2.25 (+1.44%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 5.1B +18.72% | 4.3B +14.24% | 3.7B +23.27% | 3.0B +15.15% | |
Cost of Revenue | 4.0B +19.02% | 3.4B +14.81% | 2.9B +24.92% | 2.4B +16.56% | |
Gross Profit | 1.0B +17.56% | 883.6M +12.12% | 788.1M +17.45% | 671.0M +10.44% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 104.3M +24.00% | 84.1M +16.23% | 72.4M +16.09% | 62.4M +11.38% | |
Total Operating Expenses | 4.6B +18.72% | 3.9B +12.33% | 3.5B +27.32% | 2.7B +15.28% | |
Operating Profit | 425.3M +18.70% | 358.3M +40.31% | 255.4M -13.97% | 296.8M +13.96% | |
Interest Income | 24.5M -14.74% | 28.7M +520.39% | 4.6M +210.65% | -4.2M -359.80% | |
Interest Expense | N/A N/A | N/A N/A | -8.1M -9.45% | -8.9M +30.40% | |
Interest Income and Expense and Net | 24.5M -14.74% | 28.7M +932.58% | -3.5M -73.68% | -13.1M +150.51% | |
Total Nonoperating Income and Expense | 30.3M +9.09% | 27.8M +59.76% | 17.4M +324.86% | -7.7M +214.34% | |
Income before Taxes | 455.6M +18.01% | 386.1M +41.55% | 272.8M -5.65% | 289.1M +12.05% | |
Income Taxes | 111.4M +27.07% | 87.6M +39.30% | 62.9M -2.37% | 64.4M +6.90% | |
Extraordinary Items | N/A N/A | 1.8M N/A | N/A N/A | 0 N/A | |
Net Income | 344.0M +15.44% | 298.0M +42.30% | 209.4M -6.80% | 224.7M +15.43% | |
Net Income from Continuing Operations Applicable to Common | 455.6M +18.01% | 386.1M +41.55% | 272.8M -5.65% | 289.1M +48.52% | |
Basic EPS and Net Income | 6.00 +14.07% | 5.26 +39.89% | 3.76 -8.07% | 4.09 +14.57% | |
Diluted EPS and Net Income | 5.84 +14.06% | 5.12 +40.27% | 3.65 -7.59% | 3.95 +15.50% | |
Basic Weighted Average Shares | 57.3M +1.15% | 56.7M +1.70% | 55.7M +1.50% | 54.9M +0.74% | |
Diluted Weighted Average Shares | 58.9M +1.09% | 58.2M +1.60% | 57.3M +0.79% | 56.9M -0.09% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 503.9M +8.46% | 464.6M -8.84% | 509.6M +61.14% | 316.3M +20.62% | |
Short-Term Investments | 68.5M +10.04% | 62.3M +261.34% | 17.2M +11.58% | 15.4M +12.19% | |
Cash and Cash Equivalents and Short-Term Investments | 572.4M +8.64% | 526.9M -0.0004% | 526.9M +58.83% | 331.7M +20.20% | |
Total Current Assets | 1.3B +9.91% | 1.2B +10.57% | 1.0B +34.03% | 781.1M +22.11% | |
Accumulated Depreciation | 550.9M +19.90% | 459.5M +15.96% | 396.2M +16.61% | 339.8M +14.89% | |
Property and Plant and Equipment and Net | 1.7B +31.40% | 1.3B +18.39% | 1.1B +9.96% | 992.0M +11.66% | |
Total Long-Term Assets | 1.7B +31.40% | 1.3B +18.39% | 1.1B +9.96% | 992.0M +11.66% | |
Total Assets | 5.5B +17.00% | 4.7B +11.77% | 4.2B +21.02% | 3.5B +21.10% | |
Income Taxes Payable | 818,000 N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 4.2M +3.45% | 4.1M +3.44% | 4.0M +1.73% | 3.9M +3.27% | |
Total Current Liabilities | 894.3M +20.30% | 743.4M +1.18% | 734.7M +26.23% | 582.1M +11.28% | |
Total Long-Term Debt | 281.9M -2.81% | 290.0M -2.64% | 297.9M -35.11% | 459.0M +27.10% | |
Total Long-Term Liabilities | 1.9B +12.33% | 1.7B +5.86% | 1.6B +20.97% | 1.4B +28.26% | |
Total Liabilities | 3.2B +14.11% | 2.8B +5.55% | 2.7B +21.65% | 2.2B +20.47% | |
Retained Earnings | 1.8B +23.09% | 1.4B +24.86% | 1.1B +20.74% | 946.3M +28.93% | |
Total Stockholders Equity | 2.2B +21.48% | 1.8B +23.14% | 1.5B +19.60% | 1.2B +22.20% | |
Total Shares Outstanding | 58.1M +1.13% | 57.4M +1.49% | 56.6M +1.68% | 55.7M +0.85% | |
Cash Flow | |||||
Cash from Operating Activities | 564.3M +62.53% | 347.2M -7.83% | 376.7M +38.22% | 272.5M -1.15% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | 84.7M N/A | |
Cash from Investing Activities | -513.2M +31.57% | -390.1M +113.50% | -182.7M -1.87% | -186.2M +7.06% | |
Dividends Paid | 14.4M +5.41% | 13.7M +6.06% | 12.9M +5.93% | 12.2M +5.37% | |
Cash from Financing Activities | -11.8M +446.25% | -2.2M +253.27% | -612,000 -98.10% | -32.3M -57.63% | |
Financials Ratio | |||||
Gross Margin | 20.54% -0.97% | 20.74% -1.86% | 21.13% -4.72% | 22.18% -4.09% | |
Operating Margin | 8.41% -0.01% | 8.41% +22.82% | 6.85% -30.21% | 9.81% -1.03% | |
Return on Assets | 6.79% +0.79% | 6.74% +22.72% | 5.49% -23.01% | 7.13% -1.17% | |
Return on Equity | 16.91% -5.55% | 17.90% +17.09% | 15.29% -22.83% | 19.81% -6.42% | |
Revenue Growth | 18.72% +31.41% | 14.24% -38.79% | 23.27% +53.59% | 15.15% +61.85% | |
Current Ratio | 1.42 -8.64% | 1.56 +9.28% | 1.42 +6.18% | 1.34 +9.73% | |
Cash Ratio | 0.56 -9.84% | 0.62 -9.90% | 0.69 +27.64% | 0.54 +8.40% | |
Debt-to-Equity Ratio | 0.13 -19.93% | 0.16 -20.86% | 0.20 -45.49% | 0.37 +3.80% | |
Debt-to-Assets Ratio | 0.05 -16.83% | 0.06 -12.86% | 0.07 -46.09% | 0.13 +4.77% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow